好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Post-Intensive Care Syndrome Impacts Quality of Life in Critically Ill Stroke Patients
Neuro Trauma, Critical Care, and Sports Neurology
S26 - Neurocritical Care (2:08 PM-2:16 PM)
002

To determine the impact of post-intensive care syndrome (PICS) on quality of life (QOL) for critically ill stroke patients admitted to a neurocritical care unit (NCCU).  

PICS has been defined in survivors of critical care by new or worsening impairments in functional ability, cognition, or mental health. Studies of PICS have excluded patients with brain injuries. Therefore, there is a dearth of data on the incidence and impact of PICS after neurocritical care (N-PICS). In this study, we included stroke patients admitted to an NCCU and hypothesized N-PICS would result in lower QOL as compared to those without N-PICS. 

Retrospective analysis of longitudinal quality-improvement data for NCCU patients admitted over a four-year period.  Phone interviews after discharge collected outcome measures of cognitive function, mental health, and functional status via Telephone Interview for Cognitive Status (TICS), modified Euro-QOL 5D, and modified Rankin Score (mRS) or Glasgow Outcome Scale-Extended (GOS-E) respectively. N-PICS was defined as impairment in at least one domain. 

1101 patients admitted with acute stroke were analyzed. Mean age was 59.8±14.6 years; 192 (48%) were women. At follow-up of 4.4±0.8 months, 446/1101 (40.5%) had died. Of survivors, n=372 (57%) were reached by phone with >1 outcome domain captured, 65.6% of whom met criteria for N-PICS with disability in one (34.9%) or more (30.6%) domains. The median QOL scores were significantly lower in patients with N-PICS: impairments in 2-3 domains median QOL score was 50 (IQR 31-60)  and impairments in 1 domain median score was 60 (IQR 46-75)  as compared to no impairments (median 80, IQR 70-90) (H=99.5, p<0.001).

N-PICS is prevalent in two-thirds of stroke patients admitted to NCCUs with impairments in at least one domain. 40% of these patients had impairment in mental health or cognition alone. Those with N-PICS had a lower QOL compared to those without N-PICS.

Authors/Disclosures
Kelsey Cacic, MD
PRESENTER
The institution of Dr. Cacic has received research support from Texas Neurological Society.
Natalie Kreitzer Natalie Kreitzer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Portola.
Neha Dangayach, MD, FAAN (Icahn School of Medicine At Mount Sinai and Mount Sinai Hospital) Dr. Dangayach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jacob's Institute. Dr. Dangayach has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dangayach has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association: SVIN journal. The institution of Dr. Dangayach has received research support from The Aneurysm and AVM Foundation. The institution of Dr. Dangayach has received research support from Neurosteer. Dr. Dangayach has received research support from Visionable. The institution of Dr. Dangayach has received research support from CeibaHealth. The institution of Dr. Dangayach has received research support from Cullman Family Foundation. Dr. Dangayach has received publishing royalties from a publication relating to health care. Dr. Dangayach has received publishing royalties from a publication relating to health care.
No disclosure on file
Brandon P. Foreman, MD (University of Cincinnati) Dr. Foreman has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB Pharma Inc. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell, Inc. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Foreman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma Inc.. The institution of Dr. Foreman has received research support from DOD/AMRMC. The institution of Dr. Foreman has received research support from Biogen, Inc.. The institution of Dr. Foreman has received research support from DOD/AFRL. The institution of Dr. Foreman has received research support from NSF SCH:INT. The institution of Dr. Foreman has received research support from NIH/NIBIB. The institution of Dr. Foreman has received research support from DOD/JWMRP. The institution of Dr. Foreman has received research support from Marinus Pharmaceuticals. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Honoraria with Natus Medical Incorporated. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Honoraria with Ceribell, Inc.. Dr. Foreman has received personal compensation in the range of $0-$499 for serving as a Peer-to-peer program honoraria with Marinus Pharmaceuticals.